ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
The Effects of Diesel Exhaust Inhalation on Vascular Function - the Role of Endothelin

This study has been completed.

Sponsors and Collaborators: University of Edinburgh
Umeå University
Information provided by: University of Edinburgh
ClinicalTrials.gov Identifier: NCT00745693
  Purpose

The purpose of this study is to identify the role of endothelin 1 (a natural vasoconstrictor) in the adverse vascular effects demonstrated after exposure to air pollution


Condition Intervention
Coronary Disease
Drug: Endothelin-1
Drug: BQ-123 and BQ-788

MedlinePlus related topics:   Air Pollution   

Drug Information available for:   BQ 123   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Basic Science, Randomized, Double Blind (Subject, Investigator, Outcomes Assessor), Crossover Assignment
Official Title:   The Effects of Diesel Exhaust Inhalation on Vascular Function - the Role of Endothelin

Further study details as provided by University of Edinburgh:

Primary Outcome Measures:
  • Change in forearm blood flow following infusion of endothelin-1 or the endothelin receptor antagonists BQ-123 & BQ-788 [ Time Frame: 2 hours after exposure ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • 24 hour mean blood pressure (ambulatory monitoring) [ Time Frame: 24 hours following the exposure ] [ Designated as safety issue: No ]
  • Systemic endothelin-1 and big endothelin-1 concentrations [ Time Frame: At baseline, and immediately, 1, 2, 3, 4, 6 and 24 hours after exposure ] [ Designated as safety issue: No ]
  • Changes in arterial stiffness (pulse-wave velocity) [ Time Frame: During and for the 1 hour after the exposure ] [ Designated as safety issue: No ]

Enrollment:   15
Study Start Date:   March 2008
Study Completion Date:   May 2008
Primary Completion Date:   May 2008 (Final data collection date for primary outcome measure)

Arms Assigned Interventions
1: Experimental
1 hour exposure to filtered air, followed by forearm venous occlusion plethysmography at 2 hours after the exposure and infusion of endothelin-1 (5pmol/min)
Drug: Endothelin-1
Intra-arterial infusion of Endothelin-1 at 5pmol/min for 1 hour during venous occlusion plethysmography
2: Experimental
1 hour exposure to filtered air, followed by forearm venous occlusion plethysmography at 2 hours after the exposure and infusion of endothelin receptor antagonists BQ-123 and BQ-788
Drug: BQ-123 and BQ-788
1 hour intra-arterial infusion of BQ-123 at 10nmol/min followed by co-infusion of BQ-788 at 1nmol/min for a further hour during forearm venous occlusion plethysmography
3: Experimental
1 hour exposure to dilute diesel exhaust (300mcg/m3), followed by forearm venous occlusion plethysmography at 2 hours after the exposure and infusion of endothelin-1 (5pmol/min)
Drug: Endothelin-1
Intra-arterial infusion of Endothelin-1 at 5pmol/min for 1 hour during venous occlusion plethysmography
4: Experimental
1 hour exposure to dilute diesel exhaust (300mcg/m3), followed by forearm venous occlusion plethysmography at 2 hours after the exposure and infusion of endothelin receptor antagonists BQ-123 and BQ-788
Drug: BQ-123 and BQ-788
1 hour intra-arterial infusion of BQ-123 at 10nmol/min followed by co-infusion of BQ-788 at 1nmol/min for a further hour during forearm venous occlusion plethysmography

Detailed Description:

Air pollution is a major problem, and can be linked to around 5% of all deaths worldwide each year. There are strong associations between air pollution exposure and heart disease but we do not yet understand how these harmful effects are mediated. Understanding this mechanism is likely to have a major impact on the way we treat patients with heart disease and have the potential to shape future environmental health policy. The upregulation of Endothelin-1 provides a plausible mechanism for these harmful effects, and we plan to investigate this in more depth in the human forearm following exposure to diesel exhaust.

  Eligibility
Ages Eligible for Study:   18 Years to 35 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes

Criteria

Inclusion Criteria:

  • Healthy male volunteers

Exclusion Criteria:

  • Use of regular medication
  • Cigarette smoking
  • Significant occupational exposure to air pollution
  • Intercurrent illness
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00745693

Locations
Sweden, Västerbottens
Umeå University    
      Umeå, Västerbottens, Sweden, SE-901 87

Sponsors and Collaborators
University of Edinburgh
Umeå University

Investigators
Principal Investigator:     Jeremy P Langrish, MB BCh MRCP     University of Edinburgh    
Study Director:     Anders Blomberg, MD     Umeå University    
Study Director:     Thomas Sandström, MD     Umeå University    
Study Director:     David E Newby, MD FRCP     University of Edinburgh    
  More Information


Publications:
Mills NL, Törnqvist H, Robinson SD, Gonzalez M, Darnley K, MacNee W, Boon NA, Donaldson K, Blomberg A, Sandstrom T, Newby DE. Diesel exhaust inhalation causes vascular dysfunction and impaired endogenous fibrinolysis. Circulation. 2005 Dec 20;112(25):3930-6.
 
Törnqvist H, Mills NL, Gonzalez M, Miller MR, Robinson SD, Megson IL, Macnee W, Donaldson K, Söderberg S, Newby DE, Sandström T, Blomberg A. Persistent endothelial dysfunction in humans after diesel exhaust inhalation. Am J Respir Crit Care Med. 2007 Aug 15;176(4):395-400. Epub 2007 Apr 19.
 
Calderón-Garcidueñas L, Vincent R, Mora-Tiscareño A, Franco-Lira M, Henríquez-Roldán C, Barragán-Mejía G, Garrido-García L, Camacho-Reyes L, Valencia-Salazar G, Paredes R, Romero L, Osnaya H, Villarreal-Calderón R, Torres-Jardón R, Hazucha MJ, Reed W. Elevated plasma endothelin-1 and pulmonary arterial pressure in children exposed to air pollution. Environ Health Perspect. 2007 Aug;115(8):1248-53.
 
Peretz A, Sullivan JH, Leotta DF, Trenga CA, Sands FN, Allen J, Carlsten C, Wilkinson CW, Gill EA, Kaufman JD. Diesel exhaust inhalation elicits acute vasoconstriction in vivo. Environ Health Perspect. 2008 Jul;116(7):937-42.
 
Vincent R, Kumarathasan P, Goegan P, Bjarnason SG, Guénette J, Bérubé D, Adamson IY, Desjardins S, Burnett RT, Miller FJ, Battistini B. Inhalation toxicology of urban ambient particulate matter: acute cardiovascular effects in rats. Res Rep Health Eff Inst. 2001 Oct;(104):5-54; discussion 55-62.
 

Responsible Party:   University of Edinburgh ( Dr Jeremy Langrish )
Study ID Numbers:   Res08/A116
First Received:   September 2, 2008
Last Updated:   September 4, 2008
ClinicalTrials.gov Identifier:   NCT00745693
Health Authority:   Sweden: Regional Ethical Review Board

Keywords provided by University of Edinburgh:
Endothelin  
Air pollution  
Diesel exhaust  
Vascular function  
exposure  

Study placed in the following topic categories:
Coronary Disease
Tryptophan
BQ 788
Heart Diseases
Myocardial Ischemia
Vascular Diseases
Cyclo(Trp-Asp-Pro-Val-Leu)
Ischemia

Additional relevant MeSH terms:
Therapeutic Uses
Cardiovascular Diseases
Cardiovascular Agents
Antihypertensive Agents
Pharmacologic Actions

ClinicalTrials.gov processed this record on October 24, 2008




Links to all studies - primarily for crawlers